MDT and patient perspectives on the safety of GLP-1 RAs and managing their side effects

touchMDT for touchENDOCRINOLOGY

Listen to key experts from a multidisciplinary team and a patient explore the safety of GLP-1 RAs and the role of patient education in managing the side effects of these agents

The multidisciplinary team and patient

• Primary Care Physician: Dr Kevin Fernando, Berwick, UK
• Diabetes Nurse Specialist: Prof. Dr Şeyda Özcan, Istanbul, Turkey
• Patient Advocate: Ms Kelly Ann Hardy, Margate, UK

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchendocrinologyime.org/mdt-integrating-glp1ras-t2d-management-from-pcp-to-patient/